SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-005469
Filing Date
2021-11-12
Accepted
2021-11-12 07:45:35
Documents
54
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xenetic_i10q-093021.htm   iXBRL 10-Q 662105
2 CERTIFICATION xenetic_ex3101.htm EX-31.1 9449
3 CERTIFICATION xenetic_ex3102.htm EX-31.2 9677
4 CERTIFICATION xenetic_ex3201.htm EX-32.1 4983
  Complete submission text file 0001683168-21-005469.txt   2959979

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE xbio-20210930.xsd EX-101.SCH 26061
6 XBRL CALCULATION FILE xbio-20210930_cal.xml EX-101.CAL 33979
7 XBRL DEFINITION FILE xbio-20210930_def.xml EX-101.DEF 134848
8 XBRL LABEL FILE xbio-20210930_lab.xml EX-101.LAB 199409
9 XBRL PRESENTATION FILE xbio-20210930_pre.xml EX-101.PRE 168834
10 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_i10q-093021_htm.xml XML 326754
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 211399633
SIC: 2834 Pharmaceutical Preparations